These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20965585)

  • 1. Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: the ARIC study.
    Alonso A; Tang W; Agarwal SK; Soliman EZ; Chamberlain AM; Folsom AR
    Int J Cardiol; 2012 Mar; 155(2):217-22. PubMed ID: 20965585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
    Folsom AR; Rosamond WD; Shahar E; Cooper LS; Aleksic N; Nieto FJ; Rasmussen ML; Wu KK
    Circulation; 1999 Aug; 100(7):736-42. PubMed ID: 10449696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.
    Tin A; Grams ME; Maruthur NM; Astor BC; Couper D; Mosley TH; Fornage M; Parekh RS; Coresh J; Kao WH
    Clin J Am Soc Nephrol; 2015 May; 10(5):784-90. PubMed ID: 25887069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostatic variables in Japanese and Caucasian men. Plasma fibrinogen, factor VIIc, factor VIIIc, and von Willebrand factor and their relations to cardiovascular disease risk factors.
    Iso H; Folsom AR; Wu KK; Finch A; Munger RG; Sato S; Shimamoto T; Terao A; Komachi Y
    Am J Epidemiol; 1989 Nov; 130(5):925-34. PubMed ID: 2510500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
    Folsom AR; Wu KK; Shahar E; Davis CE
    Arterioscler Thromb; 1993 Dec; 13(12):1829-36. PubMed ID: 8241104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic and inflammatory risk factors for intracerebral hemorrhage in a pooled cohort.
    Sturgeon JD; Folsom AR; Longstreth WT; Shahar E; Rosamond WD; Cushman M
    Stroke; 2008 Aug; 39(8):2268-73. PubMed ID: 18535282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study.
    Aronis KN; Zhao D; Hoogeveen RC; Alonso A; Ballantyne CM; Guallar E; Jones SR; Martin SS; Nazarian S; Steffen BT; Virani SS; Michos ED
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of inflammatory and hemostatic markers with stroke and thromboembolic events in atrial fibrillation: a systematic review and meta-analysis.
    Wu N; Chen X; Cai T; Wu L; Xiang Y; Zhang M; Li Y; Song Z; Zhong L
    Can J Cardiol; 2015 Mar; 31(3):278-86. PubMed ID: 25746020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is von Willebrand factor associated with stroke and death at mid-term in patients with non-valvular atrial fibrillation?
    Ancedy Y; Berthelot E; Lang S; Ederhy S; Boyer-Chatenet L; Di Angelantonio E; Soulat-Dufour L; Etienney A; Adavane-Scheublé S; Boccara F; Cohen A
    Arch Cardiovasc Dis; 2018 May; 111(5):357-369. PubMed ID: 29685722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel.
    Prasad RN; Koh SC; Viegas OA; Ratnam SS
    Clin Appl Thromb Hemost; 1999 Jan; 5(1):60-70. PubMed ID: 10725985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.
    Roldán V; Marín F; Muiña B; Torregrosa JM; Hernández-Romero D; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2011 Jun; 57(25):2496-504. PubMed ID: 21497043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation.
    Krishnamoorthy S; Khoo CW; Lim HS; Lane DA; Pignatelli P; Basili S; Violi F; Lip GY
    Eur J Clin Invest; 2013 Oct; 43(10):1032-8. PubMed ID: 23961715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.
    Bash LD; Erlinger TP; Coresh J; Marsh-Manzi J; Folsom AR; Astor BC
    Am J Kidney Dis; 2009 Apr; 53(4):596-605. PubMed ID: 19110358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
    Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
    Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation.
    Fu R; Wu S; Wu P; Qiu J
    Europace; 2011 Jan; 13(1):31-6. PubMed ID: 20852292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.
    Tóth NK; Csanádi Z; Hajas O; Kiss A; Nagy-Baló E; Kovács KB; Sarkady F; Muszbek L; Bereczky Z; Csiba L; Bagoly Z
    Biomed Res Int; 2017; 2017():3678017. PubMed ID: 28713823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation.
    Li-Saw-Hee FL; Blann AD; Edmunds E; Gibbs CR; Lip GY
    Clin Cardiol; 2001 May; 24(5):409-14. PubMed ID: 11346250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation.
    Conway DS; Pearce LA; Chin BS; Hart RG; Lip GY
    Circulation; 2003 Jul; 107(25):3141-5. PubMed ID: 12796127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
    Kahn SR; Solymoss S; Flegel KM
    CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation.
    Lip GY; Lane D; Van Walraven C; Hart RG
    Stroke; 2006 Sep; 37(9):2294-300. PubMed ID: 16888271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.